2010 Aug 9. [Epub ahead of print]
[Thyroid dysfunction in patients with advanced renal cell carcinoma treated with sunitinib: A multifactorial issue.]
[Article in Spanish]
Fuertes Zamorano N, De Miguel Novoa MP, Molino González A, Díaz Pérez JA, Rojas-Marcos PM, Montañez Zorrilla MC.
Servicio de Endocrinología y Nutrición, Hospital Clínico San Carlos, Madrid, España.
Abstract
OBJECTIVE: Several studies have reported the substantial prevalence of sunitinib-induced thyroid dysfunction.